We are live on ! Find out more
FOMX

Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX

Delisted

FOMX was delisted on the 6th of March, 2020.

Back to rankings

72 hedge funds and large institutions have $143M invested in Foamix Pharmaceuticals Ltd. Ordinary Shares in 2015 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 30 increasing their positions, 17 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 17

13% more capital invested

Capital invested by funds: $127M → $143M (+$16.7M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less funds holding

Funds holding: 77 → 72 (-5)

33% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 12

Holders
72
Holders Change
-5
Holders Change %
-6.49%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
30
Reduced
17
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SAM
Senzar Asset Management
New York
+$4.73M
2
DA
DSC Advisors
Illinois
+$3.05M
3
BFA
BlackRock Fund Advisors
California
+$2.78M
4
OM
Opaleye Management
Massachusetts
+$1.61M
5
JP Morgan Chase
JP Morgan Chase
New York
+$1.54M

Top Sellers

1
PHS
PFM Health Sciences
California
-$3.72M
2
AC
Ascend Capital
California
-$1.93M
3
UBS AM
UBS AM
Illinois
-$1.83M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$1.64M
5
EI
EAM Investors
California
-$1.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$16.6M – – –
Franklin Resources
2
Franklin Resources
California
$13.6M -$128K -17,140 -1%
SAM
3
Senzar Asset Management
New York
$12.1M +$4.73M +633,023 +73%
DA
4
DSC Advisors
Illinois
$11.4M +$3.05M +408,597 +41%
MMH
5
Menora Mivtachim Holdings
Israel
$11M – – –
BFA
6
BlackRock Fund Advisors
California
$7.85M +$2.78M +371,311 +62%
DM
7
Deerfield Management
New York
$7.7M – – –
TCM
8
Tekla Capital Management
Massachusetts
$5.29M +$288K +38,568 +6%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$5.28M -$896K -119,828 -16%
DCM
10
Driehaus Capital Management
Illinois
$5.19M +$685K +91,654 +17%
JGC
11
J. Goldman & Co
New York
$4.7M +$786K +105,190 +22%
Alyeska Investment Group
12
Alyeska Investment Group
Illinois
$4.38M +$227K +30,411 +6%
OM
13
Opaleye Management
Massachusetts
$4.05M +$1.61M +215,000 +75%
SCM
14
Sio Capital Management
New York
$3.37M +$596K +79,686 +24%
SFM
15
Sphera Funds Management
Israel
$2.77M -$284K -38,000 -10%
State Street
16
State Street
Massachusetts
$2.28M +$304K +40,700 +17%
CCM
17
Cadian Capital Management
New York
$2.17M – – –
SM
18
Sabby Management
Florida
$1.93M -$37.1K -4,961 -2%
FHAM
19
Folger Hill Asset Management
New York
$1.93M +$1.78M +237,995 New
Baillie Gifford & Co
20
Baillie Gifford & Co
United Kingdom
$1.78M – – –
JP Morgan Chase
21
JP Morgan Chase
New York
$1.67M +$1.54M +206,000 New
Northern Trust
22
Northern Trust
Illinois
$1.66M +$53.9K +7,214 +4%
BIT
23
BlackRock Institutional Trust
California
$1.54M +$69.9K +9,352 +5%
Millennium Management
24
Millennium Management
New York
$912K -$344K -45,970 -29%
MC
25
Menta Capital
California
$884K +$129K +17,200 +19%
1
2 3 4

FOMX Hedge Fund Activity: Q4 2015 in Review

72 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) for Q4 2015, worth a combined $143M — up 13% from $127M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of FOMX and 8 opened new positions — a net loss of 4 holders — while 17 trimmed existing stakes and 30 added.

The largest buyer was Senzar Asset Management, adding an estimated $4.73M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $3.72M sold.

  • 72 institutional investors held Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) as of Q4 2015, down from 77 in Q3 2015.
  • Funds reported $143M of Foamix Pharmaceuticals Ltd. Ordinary Shares stock for Q4 2015, up 13% quarter-over-quarter.
  • 8 funds opened new Foamix Pharmaceuticals Ltd. Ordinary Shares positions in Q4 2015 and 12 closed out, a net change of -4 holders.
  • The largest Foamix Pharmaceuticals Ltd. Ordinary Shares buyer in Q4 2015 was Senzar Asset Management, an estimated $4.73M added.
  • The largest Foamix Pharmaceuticals Ltd. Ordinary Shares seller in Q4 2015 was PFM Health Sciences, an estimated $3.72M sold.

Based on aggregated 13F filings for Q4 2015.